Sunday, September 21, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Riskified Analyst Projections and Moderate Buy Consensus

Elaine Mendonca by Elaine Mendonca
February 5, 2024
in Breaking News
0
Finances-and-tech
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Riskified (NYSE: RSKD) has undergone analysis by four analysts over the past three months, each offering their unique perspectives on the company’s future. The collective opinion of these analysts reveals a moderate buy consensus, as determined by the ratings of six Wall Street analysts. Among these ratings, two are classified as buy, four as hold, and none as sell.

Looking at the 12-month average price target for Riskified, it stands at $5.33. This represents a potential upside of 13.04% from the current price. It is worth noting that this average price target is slightly lower than the previous average of $5.88, indicating a decline of 14.97%. The most recent actions taken by analysts, as well as their corresponding price targets, are summarized in the table below:

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Gil Luria DA Davidson Announces Neutral $5.00 –
Timothy Chiodo UBS Lowers Neutral $5.00 $5.75
Tien-Tsin Huang JP Morgan Lowers Neutral $5.00 $6.00
Brent Bracelin Piper Sandler Maintains Overweight $5.00 –

The recent ratings and price targets suggest a neutral outlook from analysts, with some of them lowering their price targets for Riskified. Over the past three months, the consensus on the stock has leaned towards an overweight position. The high estimate stands at $7.50, the median at $5.00, and the low at $4.50.

Overall, the stock has a moderate buy consensus, based on the ratings of six Wall Street analysts. The recent actions and price targets from these analysts reflect the ever-changing market conditions and the performance of the company. They provide valuable insights into how analysts perceive the current state of Riskified.

In conclusion, the analyst projections for Riskified indicate a moderate buy consensus, with a 12-month average price target of $5.33. This suggests a potential upside of 13.04% from the current price. While some analysts have adjusted their price targets lower, the overall outlook remains neutral.

RSKD Stock Analysis: Price Momentum Declines on February 5, 2024

On February 5, 2024, RSKD stock experienced a slight decline in its price momentum. According to data from CNN Money, RSKD is currently trading in the middle of its 52-week range and is above its 200-day simple moving average.

The price of RSKD shares decreased by $0.10 since the market last closed, representing a drop of 2.08%. This decline may indicate a temporary setback for the stock.

Furthermore, on that day, RSKD opened at $4.62, which was $0.09 lower than its previous close. This lower opening price suggests that there may have been some selling pressure or negative sentiment surrounding the stock at the beginning of the trading session.

Investors should analyze the company’s financial health, industry trends, and market conditions to make informed decisions about their investments.

RSKD Stock Performance on February 5, 2024: Mixed Revenue Growth and Income Challenges

RSKD Stock Performance on February 5, 2024: A Mixed Bag of Revenue Growth and Income Challenges

Introduction:
On February 5, 2024, RSKD stock experienced a mixed performance, with the company’s total revenue showing a significant increase over the past year but remaining stagnant in the last quarter. Meanwhile, the net income saw a substantial rise compared to the previous year but declined in the last quarter. Additionally, earnings per share (EPS) demonstrated a notable improvement on an annual basis but experienced a decline in the most recent quarter. In this article, we will delve into the details of RSKD’s financial performance and analyze the implications for investors.

Total Revenue:
RSKD’s total revenue for the past year amounted to $261.25 million, marking a 14.01% increase compared to the previous year. However, it is worth noting that the total revenue remained flat at $71.87 million in the last quarter.

Net Income:
The net income for RSKD showed a significant improvement over the past year, increasing by 41.87% to reach -$103.99 million. However, in the last quarter, the net income declined by 23.86% to -$20.93 million.

Earnings per Share:
RSKD’s earnings per share (EPS) demonstrated a remarkable improvement on an annual basis, rising by 73.49% to -$0.62. However, in the last quarter, EPS declined by 21.93% to -$0.12.

Implications for Investors:
The mixed performance of RSKD’s financial indicators on February 5, 2024, presents a complex picture for investors. While the company has shown positive growth in total revenue and net income on an annual basis, the decline in the last quarter raises concerns about its short-term performance. Additionally, the drop in EPS during the last quarter suggests a potential decrease in profitability per share.

Investors should consider various factors before making decisions regarding RSKD stock. It is crucial to analyze the reasons behind the decline in net income and EPS in the last quarter, as well as monitor any potential changes in the company’s business strategy. Furthermore, keeping an eye on RSKD’s competition and market trends can provide valuable insights into the company’s future prospects.

Conclusion:
RSKD’s stock performance on February 5, 2024, showcased a mixed bag of revenue growth and income challenges. While the company experienced a notable increase in total revenue and net income on an annual basis, the last quarter saw a decline in both indicators. Similarly, the earnings per share improved significantly over the past year but declined in the most recent quarter. Investors should carefully evaluate these financial metrics and consider the underlying factors influencing RSKD’s performance before making investment decisions.

Tags: RSKD
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Amgens Upcoming Quarterly Earnings Report and its Potential Impact on Stock Price

Significant Surge in Short Interest for Republic Services Inc NYSE RSG Indicates Bearish Sentiment

Insurance company Stock Market Today

Progressive A Standout Company with Exceptional Market Performance and Social Responsibility

Recommended

WNS Announces Revised Fiscal 2024 Earnings Forecast and Growth Strategy

2 years ago
USMC stock news

Gulf International Bank UK Ltd Cuts Holdings in MongoDB, but the Company Continues to Thrive with Impressive Quarterly Earnings

2 years ago
MA stock news

Analyst Reaffirms Neutral Rating on Solo Brands with Adjusted Price Target

2 years ago

Processa Pharmaceuticals Implements Reverse Stock Split to Enhance Shareholder Value

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla Tilray TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

A Contrarian Bet: Institutional Investors Back FormFactor Despite Headwinds

Strategic Alliance with Google Marks Potential Turning Point for PayPal

Strategic Acquisition Propels National Bank Holdings to New Heights

Cinemark Stock: A Battle Between Strategic Moves and Market Skepticism

Microsoft’s Dividend Boost Contrasts with Share Price Performance

Navient Stock: A Study in Contrasts Amid Dividend Payouts and Market Concerns

Trending

Zimmer Biomet Stock
Analysis

Zimmer Biomet Receives Dual Analyst Endorsements Ahead of Earnings

by Dieter Jaworski
September 21, 2025
0

A pair of significant analyst upgrades have generated renewed optimism for Zimmer Biomet Holdings, Inc., marking a...

Airbnb Stock

Navigating Regulatory Headwinds: Airbnb’s Ambitious Growth Strategy Faces Critical Test

September 21, 2025
Super Micro Computer Stock

Super Micro Computer Accelerates Growth with New AI Infrastructure Rollout

September 21, 2025
FormFactor Stock

A Contrarian Bet: Institutional Investors Back FormFactor Despite Headwinds

September 21, 2025
PayPal Stock

Strategic Alliance with Google Marks Potential Turning Point for PayPal

September 21, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Zimmer Biomet Receives Dual Analyst Endorsements Ahead of Earnings
  • Navigating Regulatory Headwinds: Airbnb’s Ambitious Growth Strategy Faces Critical Test
  • Super Micro Computer Accelerates Growth with New AI Infrastructure Rollout

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com